COVID-19 Statement
Please view our statement here
We've given GeneHealth, part of Check4Cancer a brand new look for 2020.

You will be redirected to our new website in 10 seconds

Thank you

Speak with one of our advisors: 0800 331 7177 or

October, 2019

Clinical Director, Vicki Kiesel presented her poster on 'The value of genetic counselling in breast cancer genetic testing' at the EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY in Barcelona from 27 Sept - 1 Oct.

September, 2019

Clinical Director Vicki Kiesel is delighted to be presenting her poster on 'The value of genetic counselling in breast cancer genetic testing' at the EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY in Barcelona from 27 Sept - 1 Oct.

December, 2018

Multiple national and international guidelines recommend that genetic testing is provided by genetic experts in the context of genetic counselling. However, there has been little research performed demonstrating the additional value of genetic counselling.  GeneHealth UK has reviewed all their patient records between the 1st January 2018 and 30th June 2018 for breast cancer.

October, 2018

GeneHealth UK is proud to announce that research regarding the awareness of Lynch Like Syndrome among clinical Genetics has been selected for presentation at the 2018 European Hereditary Tumour Board meeting in NICE.

The research, presented by Genetic Director, Vicki Kiesel and Genetic Counsellor, Demetra Georgio, reflects the quality of clinical activity within GeneHealth UK.

For more information about EHTG please go to:

October, 2018

Direct-to-consumer testing is an affordable way to better understand your DNA, but is this a leap forward in innovation or another layer clouding an already complex market? From anxious patients to unnecessary surgeries, Genetic Director Vicki Kiesel speaks with Blue Latitude Health to help reveal the barriers for healthcare professionals and patients, and how to solve these industry challenges. 


Click on the link here to access a report on the discussion: The dark side of direct-to-consumer genetic tests

September, 2018

GeneHealth UK's Genetic Director, Vicki Kiesel, will be speaking at the Royal Society of Medicine 5th Annual Breast Cancer Forum on Friday 14th September 2018.  Delegates will learn about the various pathological, genetic and lifestyle risk factors of breast cancer, as well as techniques for detecting and preventing breast cancer, and review the latest treatments and procedures on offer.  Vicki will be talking about: 'Genetic counselling: a counsellor-patient interaction'.

May, 2018

Check4Cancer is delighted to announce the appointment of Louise Mills as Director of Clinical Services.

May, 2018

April is Bowel Cancer Awareness Month, and an ideal chance to take a look at the nature of bowel cancer, the crucial importance of early diagnosis and the value of screening and genetic testing.

February, 2018

Check4Cancer is delighted to announce that audit data from both our OneStop breast diagnostic services (through BreastHealth UK) and our genetics testing pathways (through GeneHealth UK) has been selected for presentation at the 2018 Association of Breast Surgery Annual Conference.

Proud that this reflects the excellent quality of everything we do as a company.

For more information on this year's event see: Association of Breast Surgery Annual Conference 2018

February, 2018

On the 12th January 2018 the FDA approved the use of Olaparib for BRCA carriers with metastatic HER2 negative breast cancer.  Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor is already established as a treatment for metastatic ovarian cancer, and is recommended by NICE in platinum sensitive relapsed ovarian cancer. However, despite growing literature supporting the benefits in breast cancer this is the first time that Olaparib’s use has been recommended as part of clinical care for breast cancer.

September, 2017

Ovarian Cancer Awareness month (September for the US and March for the UK) aims to increase the knowledge of ovarian cancer symptoms and therefore early diagnosis. At GeneHealth UK we are passionate about working towards early detection and prevention: accurate risk assessment and genetic testing are a vital part in this.

Unfortunately, three quarters of women who develop ovarian cancer are diagnosed after the cancer has already spread, making treatment more difficult and reducing their chance of survival. Conversely for those women diagnosed at an early stage ovarian cancer is much more treatable; which is why increasing awareness is so important.

July, 2017

Professor Dame Sally Davies, Chief Medical Officer for England, calls for Whole Genome Sequencing to be offered to all cancer patients.

Prof Dame Sally Davies’, annual report was published on the 4th July 2017 calling for Whole Genome Sequencing (WGS) to be offered to all cancer patients. WGS analyses an individual’s entire genome; looking at all 20 000 genes as well as the “packaging material” known as introns. Genomic testing can be used to target cancer treatment and prevention.

April, 2017

In February 2017, the NICE committee released guidelines recommending screening all individuals with bowel (colorectal) cancer for Lynch syndrome. Lynch syndrome is the most common cause of inherited bowel cancer and increases the risk of developing colorectal cancer as well as a number of other cancers, including ovarian and endometrial cancer in women.          

January, 2017

Genetic Director at GeneHealthUK, Vicki Kiesel will be a speaker at the Festival of Genomics on 1st February 2017. The Festival will be held from 31st Jan to 1st Feb at Excel, London and aims to help bring the benefits of genomics to patients faster.

You can find out more about the Festival via this link to the event website:


July, 2016

New research suggests that a “silent” red hair gene could significantly increase individuals’ risk of skin cancer – and as many as one in four in the UK could be carriers.

The research, led by a team at the Sanger Institute near Cambridge, confirmed that gene variants associated with red hair, pale skin and freckles are linked to a higher number of genetic mutations in skin cancers. The burden of mutations associated with these variants is comparable to an extra 21 years of sun exposure in people without this variant.

July, 2016

The Genetic Counsellor Registration Board (GCRB) recently announced that the GCRB’s register has been accredited by the Professional Standards Authority under its Accredited Registers programme.

Accreditation means that the GCRB has met the Authority’s demanding standards in the areas of governance, setting standards, education and training, managing the register, providing information and complaints handling.

July, 2016

Many of those planning a family will never have heard of Tay-Sachs disease – but its effects can be devastating.

Tay-Sachs disease is a fatal genetic disorder that causes progressive damage to the nervous system [source: NHS Choices]. Symptoms usually begin before a baby is six months old, causing their development to slow and progressively limiting their ability to move. Other early signs include the baby being excessively startled by sudden noises and red dots appearing near the middle of the eyes. These are followed by muscle weakness, loss of vision and hearing, and seizures.

June, 2016

A poster presented at the European Society of Human Genetics conference in May 2016 by GeneHealth UK highlights a case that could have profound implications for assessing cancer risk.

May, 2016

As we become more aware of cancer, we also become wise to the factors that can put us more at risk and how to manage them – minimising sun exposure to reduce risk of skin cancer, for example, or avoiding smoking to protect our lungs. Whilst the links between diet and bowel cancer are not so straightforward, it makes good sense to eat healthily, moderate our alcohol intake and also take exercise for better general health.

April, 2016

GeneHealth UK, a well-established national genetic counselling & testing company, recently demonstrated the power of mass parallel gene sequencing and the wide ranging implications for an entire family.

April, 2016

Vicki Kiesel, Genetic Director at GeneHealth UK, recently registered as a genetic counsellor in Europe, making her the first person in the world to become registered as a genetic counsellor in England, Europe and the United States.

January, 2016

GeneHealth UK (part of the Check4Cancer Ltd group of companies) is delighted to announce the consultation of Dr Antonis Pantazis as Clinical Advisor - Cardio.

December, 2015

In the past year, cheap genetic tests have started to become fashionable, promising customers insights into their health, their likely reactions to certain medications and information about their ancestry. You can now even order the testing kits as a gift to a friend or relative.

Among experts, however, some of these cut-price services are ringing alarm bells.

December, 2015

Doctor in the House is a three-part health series which sees three normal families inviting a doctor into their lives for two months, to undergo the health MOT of a lifetime.

October, 2015

A recent report on the BBC website highlights a breakthrough discovery in relation to bowel cancer.

According to new findings by a team from the Institute of Cancer Research, bowel cancer is four distinct diseases, each with a different prognosis. The team hopes that better understanding of the way these function could allow doctors to tailor treatments more effectively to individual patients, by identifying those who need more aggressive treatment, as well as sparing those who don’t.

October, 2015

A research team from the Wellcome Trust Sanger Institute in Cambridge has found a clue as to why some breast cancers relapse – a discovery that could be the key to more effective treatment.

About one in five people with breast cancer suffer a relapse, with the cancer retunring either in the same place as the original tumour or in another part of the body.

October, 2015

To mark Breast Cancer Awareness Month, Professor Gordon Wishart – Gordon Wishart, Professor of Cancer Surgery and Medical Director of Check4Cancer – talks about the importance of breast screening, why it is a success story and how women can help to reduce their own risk.

September, 2015

Genetics play a major role in our health and wellbeing.

Just as they determine hair colour and personality, genes also influence what medical conditions are passed down from our parents.

Faulty genes can trigger health problems including growth disorders, heart conditions and cancer.

September, 2015

Earlier this year, we reported on the new cancer task force, set up to combat long waiting times for diagnoses in England – 25% of which were being made too late. Now, further plans have been unveiled, including a target of 95% of people being given a diagnosis or the all-clear within 28 days of being referred by their GP, by 2020.

Figures released in May showed that more than 21,000 people had not been treated within 62 days of their cancer diagnosis in the last financial year, and the NHS had failed to achieve its own targets for treatment. According to these, 85% of cancer patients should be treated within 62 days of being urgently referred by their GP, but just 83.4% were seen on time in 2014-15. While survival rates have been improving, England still lags behind some of the best performing countries. A cross-party committee of MPs recently warned that England’s cancer services had “lost momentum”.

August, 2015

Aspirin can more than halve bowel cancer risk in obese people with Lynch syndrome – an inherited condition linked to an increased risk of cancer – according to data from a UK clinical trial.

The new analysis of the CAPP2 trial, reported by Cancer Research UK, showed that obesity heightened the risk of bowel cancer among people with the condition, who already have a much higher risk of bowel and other cancers than the general population.

August, 2015

Regular consumption of caffeinated coffee may help prevent the return of colon cancer after treatment and improve the chances of a cure, according to a new, large study from Dana-Farber Cancer Institute that reported this striking association for the first time.

The patients, all of them treated with surgery and chemotherapy for stage III colon cancer, had the greatest benefit from consuming four or more cups of coffee a day (about 460 milligrams of caffeine), according to the study published in the Journal of Clinical Oncology. These patients were 42% less likely to have their cancer return than non-coffee drinkers, and were 33% less likely to die from cancer or any other cause.

July, 2015

This week, Sarah Montague – a night-time presenter for the BBC – investigated the impact of shift work on health, and found that regular disruption of normal sleep patterns can significantly raise your susceptibility to serious illness, including cancer.

In the programme The Night Shift, broadcast on BBC Radio 4 on Monday 27 July, 8.00pm-8.30pm, Sarah Montague, explored how sleeping affects our bodies in the company of two fellow night-workers.

July, 2015

In collaboration with GeneHealth UK, Spire Cardiff Hospital has launched a genetic testing & counselling service. GHUK offers an array of tests including Next generation sequencing for cancer genetic testing, a genetic counselling service and preconception testing. Although the cancer service is open to all, it is recommended for high-risk patients such as anyone diagnosed with cancer at a young age or diagnosed with more than one cancer, the Jewish community and anyone with a strong family history of the disease.

July, 2015

In Cancer: The challenge facing the NHS BBC Health Correspondent Nick Triggle reveals the issues ahead for our struggling health service.

The analysis comes after the recent announcement of a new strategy by NHS England’s cancer taskforce aimed at improving cancer care. Figures released in May showed that more than 21,000 people had not been treated within 62 days of their cancer diagnosis in the last financial year. According to NHS targets, 85% of cancer patients should be treated within 62 days of being urgently referred by their GP, but just 83.4% were seen on time in 2014-15. While survival rates have been improving, England still lags behind some of the best performing countries.

June, 2015

In March this year, GeneHealth UK began holding regular clinics at the Platinum Medical Centre. Sessions are run by genetic counsellor, Vicky Kiesel, who offers private genetic tests for a range of cancers, including breast, prostate, bowel and ovarian. Although cancer is not often inherited, in some families there may be an increased risk due to a genetic mutation.

June, 2015

An article "Cambridge breast cancer surgeon Prof Gordon Wishart launches new genetic testing company", based on interview with Professor Gordon Wishart, was published By Cambridge News today.

June, 2015

The Times reported recently on a call for all women to be screened for “Angelina Jolie-type genetic mutations” to prevent thousands of cases of cancer.

According to experts at the world’s biggest cancer conference in the United States, routine testing for BRCA mutations was a “no-brainer” that would save hundreds of lives a year, identifying women at higher risk in their 20s or 30s and so allowing them to opt for intensive screening or preventive surgery.

June, 2015

Association Of Breast Surgery Conference & AGM,   15th & 16th June 2015,  Bournemouth International Centre

March 2015: Last Wednesday, one of the GeneHealth UK’s private clinics, The Wellington Hospital, held an educational seminar in London’s West End to update GPs about the issues surrounding ovarian cancer – one of a group of events organised to coincide with Ovarian Cancer Awareness Month. Entitled, Ovarian Cancer: Every Woman Counts, the session covered topics including diagnosis, chemotherapy resistance, and radical approaches to ovarian and uro-gynaecology surgery.

31st March: The BBC has reported this week that the TV star and former fashion reporter Kelly Osbourne is to opt for surgery to remove her ovaries as a preventative measure against ovarian cancer.

25th February:In a documentary aired on BBC Radio 1 last night (24 February), 1Xtra presenter Claira Hermet explored her decision to go for a preventative double mastectomy to reduce her risk of breast cancer.

24th March: The BBC reported today that actress Angelina Jolie has had her ovaries and fallopian tubes removed as a preventative measure against ovarian cancer.

Jolie – whose mother, grandmother and aunt all died of cancer – carries the mutated gene BRCA1, which significantly increases the carriers risk of developing cancer, specifically breast and ovarian cancer.

February 2015: A BBC report last Friday highlighted the fact that patients in Wales are being refused a test for a gene that increases cancer risk, even though they would qualify for it if they lived over the border in England.

February 2015: This week saw a BBC news report on cancer that contained shocking news for the UK. ‘Half of UK people will get cancer’ revealed that one in two people in the UK will be diagnosed with cancer at some point in their lives.

January 2015: Educational resource to highlight latest developments and show how genetic testing can improve outcomes for patients.

Cambridge-based genetic testing specialists GeneHealth UK will be offering a series of online training seminars specifically aimed at oncologists. Launching in February 2015, the seminars are designed to bring oncologists up to speed with the very latest developments in the fast-moving world of genetic research, and increase awareness of methods that could save lives.

January 2015: Check4Cancer Ltd (Check4Cancer) is pleased to announce the consultation of three new company employees across its Client Service, Marketing and Finance divisions. Cambridge based Check4Cancer has appointed Lene Farmer as Client Services Manager, Indre Peciunaityte as Marketing Manager and Reka Fogarasi as Finance Assistant.

January 2015: The genetic testing and counselling expertise provided by Cambridge-based GeneHealth UK is now being offered as an international service – via remote consultation.

“The majority of our service is focused on cancer,” explains GeneHealth UK’s Genetic Director, Vicki Kiesel. “If a patient has either been diagnosed with cancer or has a family history of cancer, they will either contact us or be referred to us. We take their medical history and family history, work out what their risk is and advise them on whether genetic testing is appropriate. We can then offer genetic tests and advise on what action to take – for example, in the case of higher breast cancer risk, whether mastectomy is an option for them as a preventative measure.”

12th December 2014: More people in high risk groups should have their DNA tested for the breast cancer genes, says a cancer charity.

Mutations in BRCA genes can give women up to an 80% chance of developing breast cancer.

February 2013: GeneHealth UK's principal Genetic Counsellor, Vicki Kiesel was selected to provide advice to the producers of BBC’s Eastenders. Read more about their BRCA storyline and what Vicki has to say about inherited breast cancer here.

October 2013: Nuffield Health and BreastHealth UK are proud to announce a collaboration which will mean an opening of a private clinic for genetic counselling and testing, backed by a leading breast consultant, based at Nuffield Health Taunton Hospital.

Read more

June 2013: Spire Bushey Hospital and BreastHealth UK are proud to announce a collaboration, which will open one of the first private clinics for genetic counselling and testing solidly backed by a leading group of private breast consultants, based at their Elstree Cancer Centre. Read a press release here

Fill out your details and one of our friendly staff will call you back within 1 working day to book your consultation with a Genetic Counsellor.

or if you prefer, call 0800 331 7177 to book now

Genetic Counselling Services
If you have a family history of cancer
Complete a referral
Refer a patient or yourself

Do you want your genes tested for cancer risk?

Book an initial 1 hour consultation for only £150 and find out if you are at risk

© 2021 GeneHealth UK, Lower Court 3-4, Copley Hill Business Park, Cambridge Road, Cambridge, CB22 3GN - Registered in England and Wales. Company registration number 08866941
All data send on this website is encrypted (SSL).